Posted on October 13, 2020

AUTHORS

Lara Labarta-Bajo, Steven P. Nilsen, Gregory Humphrey, Tara Schwartz, Karenina Sanders, Austin Swafford, Rob Knight, Jerrold R. Turner, and Elina I. Zuñiga

 

SUMMARY

Intestinal barrier leakage constitutes a potential therapeutic target for many inflammatory diseases and represents a disease progression marker during chronic viral infections. However, the causes of altered gut barrier remain mostly unknown. Using murine infection with lymphocytic choriomeningitis virus, we demonstrate that, in contrast to an acute viral strain, a persistent viral isolate leads to long-term viral replication in hematopoietic and mesenchymal cells, but not epithelial cells (IECs), in the intestine. Viral persistence drove sustained intestinal epithelial barrier leakage, which was characterized by increased paracellular flux of small molecules and was associated with enhanced colitis susceptibility. Type I IFN signaling caused tight junction dysregulation in IECs, promoted gut microbiome shifts and enhanced intestinal CD8 T cell responses. Notably, both type I IFN receptor blockade and CD8 T cell depletion prevented infection-induced barrier leakage. Our study demonstrates that infection with a virus that persistently replicates in the intestinal mucosa increases epithelial barrier permeability and reveals type I IFNs and CD8 T cells as causative factors of intestinal leakage during chronic infections.

 

REFERENCES

Labarta-Bajo, L., Nilsen, S.P., Humphrey. G., et al. Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection. J Exp Med (2020) 217 (12): e20192276. https://doi.org/10.1084/jem.20192276.

 

PRODUCT HIGHLIGHTS

The following Bio X Cell in vivo monoclonal antibodies were featured in the publication: 

The Bio X Cell Singapore website will permanently redirect to https://bioxcell.com/ from 30th April 2026.

This transition is designed to streamline access to new products, product data, technical resources, and provide a smoother ordering experience through our unified global platform.

All products, documentation, and customer support will continue to be available at: https://bioxcell.com/

https://bxcell.sg/ will remain active temporarily to support this transition before redirecting automatically.

Please update your bookmarks to https://bioxcell.com/.

For regional support, please refer to https://bioxcell.com/our-distributors.

For Singapore customers, please contact our authorized distributor, Omnicell Pte Ltd:-

eMail : enquiry@omnicell.com.sg ; Tel : 67470201

Website : www.omnicell.com.sg 

Do not show this again [ CLOSE ]